Topic: MS

OCT – diagnosis and prognosis

November 8, 2023  

Novel treatments: targeting CD40 ligand

November 1, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – FRIDAY, OCTOBER 13 EDITION

October 13, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – THURSDAY, OCTOBER 12 EDITION

October 12, 2023  

ECTRIMS-ACTRIMS 2023 HIGHLIGHTS – WEDNESDAY, OCTOBER 11 EDITION

October 11, 2023  

EYE TRACKING AS A BIOMARKER OF MS SEVERITY (NEUROSOUND PODCAST)

October 3, 2023  

CLINICAL CASES IN MS – WORSENING SYMPTOMS PRIOR TO OCRELIZUMAB INFUSION

September 27, 2023  

Ofatumumab – update on long-term efficacy, safety

September 25, 2023  

K-index a predictor of T2 lesions in CIS, RIS

September 14, 2023  

TERIS trial: final results

September 7, 2023